In this episode, Dr. Huber dives into the complex—and often heartbreaking—barriers patients face when trying to access life-saving diabetes medications like Ozempic, Mounjaro, and others in the GLP-1 and SGLT2 classes.
These medications aren't new. They've evolved over the years and offer more than just buzzworthy weight loss—they reduce the risk of heart attack, stroke, kidney disease, and even dementia. Yet as the medical benefits become clearer, so do the roadblocks: skyrocketing deductibles, insurance denials, and unjust systems that withhold care.
Dr. Huber breaks down:
Why these medications matter far beyond weight loss
The dangerous ways insurance companies are inflating costs
What real advocacy looks like from a doctor who still prays for discernment every night
This one is personal.
If you're a patient struggling to access your meds, or a doctor trying to fight the good fight—this episode will give you clarity, compassion, and the courage to keep pushing forward.
Subscribe, share, and let's get back to the heart of medicine.
#DrHuberShow #ModernMedicine #GLP1 #OzempicTruth #MounjaroAccess #PatientAdvocacy #FixHealthcare #WeightLossMedicine #DiabetesCare #YouDeserveBetter
